HPSE and neoplasm: Of note, anti-myeloma chemotherapy stimulates the elevated secretion of EVs containing high levels of heparanase on their surface, which degrade ECM and can be transferred to both tumor and host cells, altering their behavior in a way that enhances tumor survival and progression [114].